301207.SZ · 华兰疫苗
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 18.96 CNY |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 93 / 84 / 78 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 21 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -34.2% |
| Distance from 52-week high | +27.2% |
| Market cap (USD) | $1.8B |